ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $874 | -78.2% | 36,483 | +11160.2% | 0.46% | +4090.9% |
| Q2 2022 | $4,000 | -89.5% | 324 | -79.5% | 0.01% | -67.6% |
| Q1 2022 | $38,000 | -50.0% | 1,584 | -51.5% | 0.03% | -68.8% |
| Q4 2021 | $76,000 | +1166.7% | 3,266 | +1196.0% | 0.11% | +1716.7% |
| Q2 2021 | $6,000 | -96.3% | 252 | -96.0% | 0.01% | -96.6% |
| Q1 2021 | $161,000 | -29.7% | 6,258 | +46.2% | 0.18% | -31.0% |
| Q4 2020 | $229,000 | +74.8% | 4,279 | +34.0% | 0.26% | +91.7% |
| Q3 2020 | $131,000 | -70.9% | 3,193 | -81.0% | 0.13% | -21.8% |
| Q2 2020 | $450,000 | +60.1% | 16,832 | +152.7% | 0.17% | -62.9% |
| Q1 2020 | $281,000 | -37.6% | 6,661 | -60.4% | 0.46% | +80.3% |
| Q2 2019 | $450,000 | +592.3% | 16,832 | +589.6% | 0.25% | +586.5% |
| Q1 2019 | $65,000 | – | 2,441 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |